OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition.

Covert, Hunter; Mellor, Liliana F; Wolf, Cody L; Ankenbrandt, Nicole; Emathinger, Jacqueline M; Tawara, Ken; Oxford, Julie Thom; Jorcyk, Cheryl L

Covert, Hunter; Mellor, Liliana F; Wolf, Cody L; Ankenbrandt, Nicole; Emathinger, Jacqueline M; Tawara, Ken; Oxford, Julie Thom; Jorcyk, Cheryl L.

Afiliação

Covert H; Boise State University, Biomolecular Sciences Program, Boise, ID 83725, USA.
Mellor LF; Boise State University, Department of Biological Sciences, Boise, ID 83725, USA.
Wolf CL; Oncología Molecular, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid 28029, Spain.
Ankenbrandt N; Boise State University, Biomolecular Sciences Program, Boise, ID 83725, USA.
Emathinger JM; Boise State University, Biomolecular Sciences Program, Boise, ID 83725, USA.
Tawara K; Boise State University, Department of Biological Sciences, Boise, ID 83725, USA.
Oxford JT; Boise State University, Biomolecular Sciences Program, Boise, ID 83725, USA.
Jorcyk CL; Boise State University, Biomolecular Sciences Program, Boise, ID 83725, USA.

Cancer Manag Res ; 11: 7721-7737, 2019.

Article em En | MEDLINE | ID: mdl-31496817

Palavras-chave

Oncostatin M; breast tumor metastasis; cluster of differentiation 44; epithelial to mesenchymal transition

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cancer Manag Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos